Revenue segments as reported by the company.

Beauty

Grooming

Health Care

Fabric & Home Care

Baby, Feminine & Family Care

Corporate

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Goodwill and indefinite-lived intangibles impairment charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Procter & Gamble

Old Spice is a brand of male grooming products encompassing deodorants and antiperspirants, shampoos, body washes, and soaps.

Old Spice

Crest is a brand of toothpaste and other oral hygiene products sold worldwide.

Crest

Tampax is a brand of tampon sold in over 100 countries.

Tampax

Tide

Braun AG, is a German consumer products company based in Kronberg. From 1984 until 2007, Braun was a wholly owned subsidiary of The Gillette Company, which had purchased a controlling interest in the company in 1967. Braun is now a wholly owned subsidiary of Procter & Gamble, which acquired Gillette in 2005. On 16 April 2012, De'Longhi bought perpetual rights to manufacture Braun branded products from Procter & Gamble in the small appliance segment. Procter & Gamble will continue to own the Braun brand.

Braun

Gillette is a brand of men's and women's safety razors and other personal care products including shaving supplies.

Gillette

Olay is a brand of beauty products focusing on skin care.

Olay

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Procter & Gamble reports strong Q3 performance and navigates challenges

Procter & Gamble delivered strong Q3 results, raising its guidance for organic sales growth and maintaining its outlook for core earnings per share growth. The company faces challenges related to sustained cost pressures, supply constraints, and volume recovery in certain regions. However, opportunities exist in travel retail reopening, innovation strategies, and continued resilience.

Procter & Gamble reports Q2 growth amid global challenges

Procter & Gamble's Q2 showed mixed results with strong U.S. sales but challenges in Greater China.
Guidance raised for organic sales growth, but significant headwinds persist from raw material costs and currency fluctuations.
Investments in brand superiority and supply chain optimization present growth opportunities.
Balancing input cost inflation and navigating market uncertainties remain key challenges.

Procter & Gamble reports robust Q3 results amidst global challenges

Procter & Gamble's Q3 performance reflects strong execution of strategies, leading to organic sales growth and margin improvement.
Despite challenges from costs and supply constraints, P&G's focus on innovation and market leadership positions it well for future growth.
Opportunities in China, Latin America, and Europe, along with continued productivity improvements, offer avenues for sustained growth and market expansion.
P&G's long-term approach to navigating challenges and serving stakeholders effectively underscores its resilience and commitment to sustainable growth.

Procter & Gamble posts robust Q4 earnings amidst market challenges

Procter & Gamble (PG) reported strong financial performance in Q4 2023 and fiscal year 2023, driven by organic sales growth and operational efficiency.
The company's strategic focus on innovation, market share growth, and cost management positions it well to navigate challenges and capitalize on opportunities.
Despite challenges in the China market and supply chain disruptions, P&G remains committed to driving growth, enhancing productivity, and delivering shareholder value.

Procter & Gamble reports strong Q1 results and outlines growth strategies

Procter & Gamble's Q1 performance reflects robust sales growth and financial strength.
While facing challenges in certain regions, the company remains focused on driving innovation and value creation.
Opportunities in commodity tailwinds and marketing investments position PG for continued growth.
Confidence in strategy and commitment to balanced growth underscore PG's resilience.

Procter & Gamble reports robust Q2 earnings amidst market challenges

Procter & Gamble's Q2 2024 earnings call showcased strong performance, emphasizing sales growth, margin improvement, and strategic focus on innovation. While facing challenges in key markets, P&G remains resilient and focused on overcoming obstacles to drive growth. The company's opportunities lie in maintaining sales growth, enhancing earnings, and strategic market decisions.

Procter & Gamble (PG) posts robust Q3 results, eyes innovation for growth

Procter & Gamble (PG) reported strong Q3 performance, highlighting growth in key markets and increased earnings. Despite challenges in China and the Middle East, the company remains focused on innovation and market growth to drive future success.

Procter & Gamble reports strong Q4 results, eyes innovation for growth

Procter & Gamble's Q4 performance showcases resilience and strategic focus amidst regional challenges. The company's emphasis on innovation, market growth, and consumer delight positions it well for sustained positive results and value creation.

Procter & Gamble reports 2% organic sales growth in Q1 2025

Procter & Gamble delivered steady organic sales growth, strong core earnings, and maintained guidance for fiscal year '25. Challenges in Greater China and Europe require attention, while opportunities in Latin America and shareholder value creation through dividends and stock repurchases are key focus areas.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Johnson & Johnson

Procter & Gamble ended fiscal 2023 strong despite inflationary pressures. Johnson & Johnson's outstanding Q2 results depict its continued strength in its business.

Better Buy: Johnson & Johnson vs. Procter & Gamble

Citigroup

Chevron

Diageo

Coca-Cola

Kroger

Mondelez

What an outstanding year it has been, after a dreadful 2022 that most stock investors are more than happy to see fade into the distance.

The 2023 Rally Could Be in Big Trouble: 7 Warren Buffett Big Dividend Stocks to Buy Now

Sales volume declines were modest this past quarter. P&G is targeting another $16 billion of cash returns this fiscal year.

3 Reasons Procter & Gamble Stock Is Still a Buy

PepsiCo

The U.S. stock market has been roaring higher lately, even though it has started off August on a tough note. While the S&P 500 has fallen about 2% so far this month, it's been on a strong run otherwise.

Buckle Up! 3 Blue-Chip Stocks Set to Soar to New Heights.

Salesforce

Visa

Salesforce.com has been at the cutting edge of cloud computing and artificial intelligence before either was on the radar of mainstream investors. Consumer goods outfit Procter & Gamble's incredible pricing power has allowed it to become one of the market's strongest dividend payers.

3 Dow Stocks to Buy More of in August

Kimberly-Clark

The Consumer Staples sector carries a defensive nature, as these companies' products have an advantageous ability to generate consistent demand in the face of many economic situations.

Buy These 3 Stocks for a Defensive Approach

Aflac

Costco

Dollar Tree

Grocery Outlet

Home Depot

Sempra Energy

While the Federal Reserve seeks to spark gentle disinflation, it can't be too soft on accelerating consumer prices either, which is exactly why investors need to consider reliable stocks during rate hikes. Sure, some recent data points to an encouraging backdrop for slowing inflation.

7 Boring Stocks That Can Thrive When Interest Rates Rise

Bristol-Myers

Danaher

ProShares S&P 500 Dividend Aristocrats ETF

Invesco S&P 500 High Beta ETF

Thermo Fisher Scientific

UnitedHealth Group

iShares Edge MSCI Min Vol USA ETF

Health Care Select Sector SPDR Fund

High-beta stocks have outperformed defensive stocks in the stock market recently, raising questions about the effectiveness of low-volatility and dividend growth investing. ROBECO's research shows that low-volatility investing can significantly improve long-term performance, particularly in market environments with increased retail investor participation. Low-risk ETFs, such as healthcare names and dividend aristocrats, offer exposure to fundamentally strong factors and tend to perform well during periods of stagflation, high inflation, and decent economic growth.

Time To Go Defensive With These ETFs

Archer-Daniels-Midland Company

Automatic Data Processing

Seasonality is a strong determinant of price movement. These three stocks are entering their strongest and most profitable periods of seasonality.

Three Stocks To Hold Through Year End

After several quarters and billions of dollars, things might be turning around for this key variable.

Procter & Gamble Reveals a Surprising Twist

Colgate-Palmolive

Investors are no longer happy with big price increases paired with volume declines.

Wall Street to Procter & Gamble, Colgate-Palmolive: Start Moving Units

Boeing

Cisco Systems

Intel

Microsoft

Travelers

Verizon

Walgreens

The Dow Jones recovered from yesterday's selloff to gain 0.5% as investors hoped that slowing inflation would end Fed rate hikes.

Dow Jones Today: Index Rebounds on Slowing Inflation

Procter & Gamble's (PG) Q4 results reflect strong gains from its pricing actions, robust demand, improved sales and margins, and a positive product mix.

Procter & Gamble (PG) Rises on Q4 Earnings Beat, Robust View

Procter & Gamble Company (NYSE:PG ) Q4 2023 Earnings Conference Call July 28, 2023 9:00 AM ET Company Participants Jon Moeller - Chairman, President, Chief Executive Officer Andre Schulten - Chief Financial Officer Conference Call Participants Bryan Spillane - Bank of America Steve Powers - Deutsche Bank Dara Mohsenian - Morgan Stanley Laura Lieberman - Barclays Nik Modi - RBC Capital Markets Robert Ottenstein - Evercore ISI Andrea Teixeira - JP Morgan Callum Elliott - Bernstein Olivia Tong - Raymond James Peter Grom - UBS Filippo Falorni - Citi Chris Carey - Wells Fargo Securities Mark Astrachan - Stifel Bill Chappell - Truist Securities Operator Good morning and welcome to Procter & Gamble's quarter end conference call. Today's event is being recorded for replay.

Procter & Gamble (PG) Q4 2023 Earnings Call Transcript

Procter & Gamble exceeded earnings and revenue estimates on higher prices, though the company warned macroeconomic challenges could impact its fiscal 2024 results.

P&G Beats Profit and Sales Estimates on Higher Prices

Procter & Gamble Co ( PG , Financial) recently saw a day's gain of 3.42%, with an Earnings Per Share (EPS) of $5.74. This article aims to answer the question: Is Procter & Gamble Co fairly valued?

Procter & Gamble Co (PG): A Fairly Valued Stock with Strong Profitability

P&G topped estimates on the top and bottom lines. The company was able to pass along price increases once again.

Why Procter & Gamble Stock Was Climbing Today

Procter & Gamble Co (NYSE: PG) inched up this morning after reporting better-than-expected results for its fourth financial quarter. P&G's guidance for the full year The consumer goods giant also said that it now expects between $6.25 a share and $6.43 a share of earnings in fiscal 2024 on a 3.

P&G says ‘momentum is generally building' after solid Q4 results

Although the revenue and EPS for P&G (PG) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Here's What Key Metrics Tell Us About P&G (PG) Q4 Earnings

Procter & Gamble (PG) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.21 per share a year ago.

Procter & Gamble (PG) Q4 Earnings and Revenues Top Estimates

Procter & Gamble (NYSE:PG) has reported fourth-quarter revenue and earnings as it benefitted from price increases. However, the consumer goods company's guidance for fiscal 2024 has fallen short of analysts' estimates.

Procter & Gamble reports 4Q earnings beat, disappoints on 2024 guidance

Procter & Gamble Co.'s stock PG, -1.19% rose 1.6% in premarket trade Friday, after the consumer goods giant blew past earnings estimates for its fiscal fourth quarter. The Cincinnati-based parent of brands including Charmin, Crest and Pampers posted net income of $3.384 billion, or $1.37 a share, for the quarter to June 30, up from $3.052 billion, or $1.21 a share, in the year-earlier period.

Procter & Gamble beats earnings estimates after again raising prices

CINCINNATI--(BUSINESS WIRE)--The Procter & Gamble Company (NYSE:PG) reported fourth quarter and fiscal year 2023 results. “The April-June quarter provided a very strong finish to fiscal year 2023 – top-line growth, bottom-line growth, and cash generation,” said Jon Moeller, Chairman of the Board, President and Chief Executive Officer. “The team met or exceeded our going-in plans for sales, earnings, and cash in a difficult operating environment and despite significant cost headwinds. As we.

News for Procter & Gamble Stock (PG)